Sensorion Hosting Key Opinion Leader Call with Dr. Michael Hoffer on Sudden Sensorineural Hearing Loss and SENS-401 as a Potential Treatment Option on July 23, 2020. pdfRead

Sensorion appoints Dr Edwin Moses, former Ablynx CEO, as Chairman of the Board. pdfRead

Sensorion announces initiation of coverage by US investment bank Chardan with a "Buy" recommendation. pdfRead

Sensorion announces positive preliminary preclinical data from its Otoferlin gene therapy program. pdfRead

Sensorion to attend Citi European Healthcare Conference. pdfRead